Afuco™ Anti-Human TGFB1 ADCC Therapeutic Antibody (LY2382770), ADCC Enhanced
Anti-TGFB1 ADCC Enhanced Antibody (LY2382770) is an ADCC enhanced antibody produced by our Afuco™ platform. LY 2382770 is a monoclonal antibody inhibitor of transforming growth factor-beta (TGF-β) kinase, for the treatment of kidney disease due to diabetes.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-583CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | TGFB1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤1 year at -20°C. |